JAMA Surgery on Mythryl: “Among patients with #Melanoma and negative #SentinelLymphNodeBiopsy…”

Among patients with #Melanoma and negative #SentinelLymphNodeBiopsy results, a low-risk 31-gene genetic expression profile identified a group with very low recurrence and no distant relapse after discharge to dermatology follow-up only. ja.ma/3UCwKoo

ja.maUse of a Genetic Expression Profile to Discharge Patients With Melanoma From Surgical ClinicsThis quality improvement study evaluates the use of a genetic expression profile to determine whether patients with negative sentinel lymph node biopsy results and low risk per American Joint Committee on Cancer guidelines can be safely discharged postoperatively.

23/10/26, 1:00 pm0 reposts0 likes

Post